Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price traded up 21.2% during mid-day trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. 292,294 shares changed hands during trading, a decline of 46% from the average session volume of 537,892 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The stock has a 50 day moving average of C$0.11 and a 200 day moving average of C$0.08. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The company has a market capitalization of C$25.10 million, a price-to-earnings ratio of -18.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- What is a Dividend King?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Are Penny Stocks a Good Fit for Your Portfolio?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Best Aerospace Stocks Investing
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
